| Chr | Position | SNPID | Disease/Trait name | pvalue | PMID |
|---|---|---|---|---|---|
| X | 68222952 | rs1022129 | Breast cancer total mortality | 5.80E-04 | 22232737 |
| X | 141616761 | rs1040472 | Gene expression of STIM2 (probeID ILMN_1738449) in breast tumors | 3.16E-04 | 22522925 |
| X | 100658972 | rs104894833 | Breast cancer | 1.00E-03 | 23555315 |
| X | 135313034 | rs1055497 | Breast cancer | 5.80E-04 | 23555315 |
| X | 22463536 | rs11094835 | Breast cancer recurrence | 5.90E-06 | 22232737 |
| X | 22463536 | rs11094835 | Breast cancer total mortality | 1.10E-05 | 22232737 |
| X | 22463536 | rs11094835 | Breast cancer (survival) | 9.60E-04 | 22232737 |
| X | 101408030 | rs11798249 | Gene expression of BEX5 (probeID ILMN_1806473) in breast tumors | 7.98E-18 | 22522925 |
| X | 14947862 | rs12390204 | Gene expression of MOSPD2 (probeID ILMN_2043569) in breast tumors | 2.54E-11 | 22522925 |
| X | 125258150 | rs12556152 | Gene expression of PIR (probeID ILMN_2383383) in breast tumors | 5.60E-04 | 22522925 |
| X | 39232009 | rs12689301 | Breast cancer | 3.00E-04 | 21908515 |
| X | 37027276 | rs142884749 | Breast cancer | 3.00E-04 | 23555315 |
| X | 84741510 | rs147717395 | Breast size (bra cup size in women) | 2.87E-05 | 22747683 |
| X | 7268296 | rs151332463 | Breast cancer (Estrogen receptor positive breast cancer) | 1.30E-04 | 23555315 |
| X | 98582299 | rs1581705 | Gene expression of NARS2 (probeID ILMN_1797332) in breast tumors | 1.91E-09 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of INTS4 (probeID ILMN_1660844) in breast tumors | 7.71E-07 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of ALG8 (probeID ILMN_1685413) in breast tumors | 2.20E-06 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of ALG8 (probeID ILMN_2365686) in breast tumors | 2.74E-06 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of CLNS1A (probeID ILMN_1736814) in breast tumors | 1.27E-05 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of KCTD21 (probeID ILMN_1809708) in breast tumors | 2.17E-04 | 22522925 |
| X | 98582299 | rs1581705 | Gene expression of RSF1 (probeID ILMN_1668834) in breast tumors | 9.18E-04 | 22522925 |
| X | 112033290 | rs16987094 | Gene expression of XIST (probeID ILMN_1764573) in breast tumors | 1.20E-04 | 22522925 |
| X | 141553680 | rs16993896 | Breast cancer risk (in BRCA1 mutation carriers) | 5.57E-05 | 20852631 |
| X | 50335675 | rs17281496 | Breast cancer | 7.86E-07 | 20852631 |
| X | 145152892 | rs17319551 | Breast cancer | 1.40E-05 | 22923054 |
| X | 14913818 | rs1858882 | Gene expression of MOSPD2 (probeID ILMN_1766094) in breast tumors | 1.59E-10 | 22522925 |
| X | 38742763 | rs199860 | Breast cancer | 4.85E-07 | 20852631 |
| X | 4531870 | rs2091519 | Gene expression of MRPL18 (probeID ILMN_1804479) in breast tumors | 1.86E-05 | 22522925 |
| X | 153239720 | rs2266888 | Gene expression of CXORF12 (probeID ILMN_2198185) in breast tumors | 4.35E-05 | 22522925 |
| X | 135310785 | rs2273221 | Breast cancer | 3.20E-04 | 23555315 |
| X | 152780887 | rs2980062 | Gene expression of IFNA8 (probeID ILMN_2110561) in breast tumors | 1.44E-24 | 22522925 |
| X | 152780887 | rs2980062 | Gene expression of RRAS2 (probeID ILMN_2077623) in breast tumors | 1.84E-09 | 22522925 |
| X | 55574773 | rs3126259 | Breast cancer | 5.00E-04 | 23555315 |
| X | 83723541 | rs35161124 | Breast cancer | 1.70E-04 | 23555315 |
| X | 13120130 | rs3863537 | Breast cancer risk (in BRCA1 mutation carriers) | 5.01E-05 | 20852631 |
| X | 42579174 | rs4084280 | Breast cancer | 3.20E-08 | 20852631 |
| X | 55137978 | rs4124595 | Breast cancer | 5.00E-04 | 23555315 |
| X | 134407153 | rs4465122 | Gene expression of ZNF75D (probeID ILMN_2101025) in breast tumors | 6.21E-115 | 22522925 |
| X | 4198722 | rs5916576 | Breast cancer | 4.12E-07 | 20852631 |
| X | 128267767 | rs5932579 | Breast size (bra cup size in women) | 4.17E-05 | 22747683 |
| X | 8010400 | rs5934349 | Breast cancer | 1.75E-04 | pha002853 |
| X | 46562925 | rs5952927 | Breast cancer early age of onset | 3.75E-04 | 18463975 |
| X | 65523670 | rs5965136 | Breast cancer (familial breast cancer) | 2.03E-05 | 23354978 |
| X | 134427640 | rs5978119 | Gene expression of ZNF75D (probeID ILMN_2101025) in breast tumors | 2.10E-18 | 22522925 |
| X | 102443308 | rs5987697 | Gene expression of BEX2 (probeID ILMN_2181892) in breast tumors | 3.77E-04 | 22522925 |
| X | 42923587 | rs5991566 | Breast cancer | 3.00E-04 | 23555315 |
| X | 32890872 | rs6527237 | Breast cancer (BRCA2-positive) | 7.95E-05 | 21060860 |
| X | 120358529 | rs6608061 | Breast cancer | 3.10E-07 | 20852631 |
| X | 38775242 | rs6610204 | Breast cancer | 4.60E-14 | 20453838 |
| X | 102477571 | rs6621629 | Gene expression of BEX4 (probeID ILMN_2351638) in breast tumors | 5.96E-05 | 22522925 |
| X | 71407938 | rs6624608 | Gene expression of PIN4 (probeID ILMN_1729515) in breast tumors | 6.37E-06 | 22522925 |
| X | 144630068 | rs6626369 | Breast cancer | 3.14E-08 | 20852631 |
| X | 13846178 | rs6633380 | Musculoskeletal adverse events (MS-AEs) in women receiving AI adjuvant therapy for early breast cancer | 3.93E-05 | 20876420 |
| X | 142600937 | rs6636987 | Gene expression of STARD13 (probeID ILMN_1666380) in breast tumors | 8.00E-04 | 22522925 |
| X | 130400308 | rs6637820 | Musculoskeletal adverse events (MS-AEs) in women receiving AI adjuvant therapy for early breast cancer | 8.21E-06 | 20876420 |
| X | 84241847 | rs722718 | Gene expression of APOOL (probeID ILMN_1777483) in breast tumors | 3.32E-05 | 22522925 |
| X | 2532771 | rs73183608 | Gene expression of LOC646154 (probeID ILMN_1661128) in breast tumors | 1.50E-07 | 22522925 |
| X | 93783154 | rs7892683 | Gene expression of PPP1R16A (probeID ILMN_1757882) in breast tumors | 2.26E-04 | 22522925 |
| X | 15900328 | rs798159 | Gene expression of U2AF1L2 (probeID ILMN_1773868) in breast tumors | 8.07E-07 | 22522925 |
| X | 143036520 | rs9306815 | Breast cancer | 9.00E-04 | 23555315 |
| X | 83808253 | rs969017 | Breast cancer | 3.20E-05 | 23555315 | Chr | Position | SNPID | Disease/Trait name | pvalue | PMID |
CopyRight © University of Miami, USA; Harbin Medical University, China
